Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Future Leader’s Award 2017 goes to UFS Quantity Surveying student
2017-08-11

Description: Future Leader’s Award 2017 goes to UFS Quantity Surveying student Tags: Future Leader’s Award 2017 goes to UFS Quantity Surveying student 

Celebrating big achievements in the construction
sector at the recent Association of South African
Quantity Surveyors (ASAQS) conference are, from
the left: Cameron Ferreira, junior lecturer in the
UFS Department of Quantity Surveying,
Jhon Thatcher, former UFS student in the same
department who was the second runner-up for the
Gold Medal Award, Dr Stephan Ramabodu, President
of ASAQS, Gerné Bothma, former student in the
department and winner of the Future Leaders’
Award 2017, and Pierre Oosthuizen, UFS lecturer in
the same department.
Photos: Supplied


The Department of Quantity Surveying and Construction Management at the University of the Free State (UFS) made good on its promise to develop independent and critical-thinking graduates who will become leaders in their field. At the recent Association of South African Quantity Surveyors (ASAQS) conference and gala dinner, two students from the department, Gerné Botma and Jhon Thatcher, received awards for their outstanding performance.

Best of the best
Botma received the ASAQS Future Leaders’ Award (2017), an award based on academic achievement in the first three years of study. He competed with nominees from universities across South Africa offering Quantity Surveying programmes, and was the winner in this category.

Thatcher was a second runner-up for the ASAQS Gold Medal Award (being in the top three Quantity Surveying students in South Africa). This is awarded on a number of criteria, including academic achievement. Fourth-year students from all the universities in South Africa offering Quantity Surveying programmes compete for this award, and must display achievement in categories such as academia, leadership, community engagement, and general interests.  In 2016, the Gold Medal Award was won by the UFS student, Kamogelo Leeuw.

Keeping abreast of developments
Today, organisations are relying on its members to stay ahead of issues, technologies, innovations and trends. In Quantity Surveying, to keep abreast of developments in the built environment, ASAQS was established as a voluntary association, with one of its goals being advancing and promoting the science and practice of Quantity Surveying.  ASAQS works in close collaboration with its member firms, tertiary institutions, and the South African Council for Quantity Surveying Professions (SACQSP), a statutory body that oversees and regulates the profession, and accredit Quantity Surveying programmes in South Africa.

Two staff members from the UFS Department of Quantity Surveying and Construction Management, Cameron Ferreira and Pierre Oosthuizen, attended the recent ASAQS annual conference. Ferreira, a junior lecturer in the department, is the current Chapter Chairperson of the Free State for ASAQS and Oosthuizen, a lecturer in the department, is the former Chapter Chairperson.

According to Ferreira, they attended the conference to keep abreast of the latest development within the industry. “The event also served as a great networking opportunity for the UFS to build partnerships with other industry pioneers,” she said. Making use of opportunities such as these is in line with the UFS’s pursuit of lifelong learning.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept